Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 148

1.

Socioeconomic Costs and Health Inequalities from Psoriasis: A Cohort Study.

Thomsen SF, Skov L, Dodge R, Hedegaard MS, Kjellberg J.

Dermatology. 2019 Jun 25:1-8. doi: 10.1159/000499924. [Epub ahead of print]

PMID:
31238322
2.

Use of the Patient Benefit Index to monitor treatment of chronic spontaneous urticaria with omalizumab.

Chodziuk AC, Ghazanfar MN, Thomsen SF.

Dermatol Ther. 2019 May;32(3):e12902. doi: 10.1111/dth.12902. Epub 2019 Apr 23. No abstract available.

PMID:
30964569
3.

IgE-Mediated Multimorbidities in Allergic Asthma and the Potential for Omalizumab Therapy.

Humbert M, Bousquet J, Bachert C, Palomares O, Pfister P, Kottakis I, Jaumont X, Thomsen SF, Papadopoulos NG.

J Allergy Clin Immunol Pract. 2019 May - Jun;7(5):1418-1429. doi: 10.1016/j.jaip.2019.02.030. Epub 2019 Mar 27. Review.

4.

Biologics for chronic inflammatory skin diseases: an update for the clinician.

Yao Y, Ravn Jørgensen AH, Thomsen SF.

J Dermatolog Treat. 2019 Mar 25:1-23. doi: 10.1080/09546634.2019.1589643. [Epub ahead of print]

PMID:
30827126
5.

Association Between Chronic Obstructive Pulmonary Disease and Type 2 Diabetes: A Systematic Review and Meta-Analysis.

Rasmussen SM, Brok J, Backer V, Thomsen SF, Meteran H.

COPD. 2018 Oct;15(5):526-535. doi: 10.1080/15412555.2018.1532495.

PMID:
30822245
6.

Determinants of disease severity among patients with atopic dermatitis: association with components of the atopic march.

Holm JG, Agner T, Clausen ML, Thomsen SF.

Arch Dermatol Res. 2019 Apr;311(3):173-182. doi: 10.1007/s00403-019-01895-z. Epub 2019 Feb 15.

PMID:
30770978
7.

Use of Complementary and Alternative Therapies in Outpatients with Atopic Dermatitis from a Dermatological University Department.

Holm JG, Clausen ML, Agner T, Thomsen SF.

Dermatology. 2019;235(3):189-195. doi: 10.1159/000496274. Epub 2019 Feb 13.

PMID:
30759429
8.

Omalizumab for atopic dermatitis: evidence for and against its use.

Holm JG, Thomsen SF.

G Ital Dermatol Venereol. 2019 Aug;154(4):480-487. doi: 10.23736/S0392-0488.19.06302-8. Epub 2019 Feb 4.

PMID:
30717578
9.

Effectiveness and safety of switching to biosimilar infliximab and etanercept in patients with psoriasis.

Lund T, Sand C, Gniadecki R, Thomsen SF.

Dermatol Ther. 2019 May;32(3):e12846. doi: 10.1111/dth.12846. Epub 2019 Feb 22. No abstract available.

PMID:
30697879
10.

Type 2 diabetes and psoriasis: links and risks.

Holm JG, Thomsen SF.

Psoriasis (Auckl). 2019 Jan 17;9:1-6. doi: 10.2147/PTT.S159163. eCollection 2019. Review.

11.

D-dimer as a potential blood biomarker for disease activity and treatment response in chronic urticaria: a focused review.

Ghazanfar MN, Thomsen SF.

Eur J Dermatol. 2018 Dec 1;28(6):731-735. doi: 10.1684/ejd.2018.3443. Review.

PMID:
30530404
12.

Hidradenitis Suppurativa: Causes, Features, and Current Treatments.

Vinkel C, Thomsen SF.

J Clin Aesthet Dermatol. 2018 Oct;11(10):17-23. Epub 2018 Oct 1. Review.

13.

Acne vulgaris in patients with hidradenitis suppurativa.

Ravn Jørgensen AH, Ring HC, Thomsen SF.

J Am Acad Dermatol. 2019 May;80(5):e129-e130. doi: 10.1016/j.jaad.2018.11.021. Epub 2018 Nov 17. No abstract available.

PMID:
30458210
14.

Asthma severity and fertility outcome in women with polycystic ovary syndrome: a registry-based study.

Zierau L, Cortes R, Thomsen SF, Jimenez-Solem E, Lindenberg S, Backer V.

ERJ Open Res. 2018 Nov 5;4(4). pii: 00138-2017. doi: 10.1183/23120541.00138-2017. eCollection 2018 Oct.

15.

Self-reported intake of fruit and vegetables and risk of chronic obstructive pulmonary disease: A nation-wide twin study.

Meteran H, Thomsen SF, Miller MR, Hjelmborg J, Sigsgaard T, Backer V.

Respir Med. 2018 Nov;144:16-21. doi: 10.1016/j.rmed.2018.09.013. Epub 2018 Sep 20.

PMID:
30366579
16.

Sample size estimation practices in research protocols submitted to Danish scientific ethics committees.

Flege MM, Thomsen SF.

Contemp Clin Trials Commun. 2018 Aug 15;11:165-169. doi: 10.1016/j.conctc.2018.08.003. eCollection 2018 Sep.

17.

Combined treatment with omalizumab and etanercept in a patient with chronic spontaneous urticaria and rheumatoid arthritis.

Ghazanfar MN, Thomsen SF.

J Dermatolog Treat. 2019 Jun;30(4):387-388. doi: 10.1080/09546634.2018.1515465. Epub 2018 Sep 25.

PMID:
30132352
18.

Association between Atopic Dermatitis and the Metabolic Syndrome: A Systematic Review.

Ali Z, Ulrik CS, Agner T, Thomsen SF.

Dermatology. 2018;234(3-4):79-85. doi: 10.1159/000491593. Epub 2018 Aug 15. Review.

PMID:
30110673
19.

Therapeutic Response to Secukinumab in a 36-Year-Old Woman with Hidradenitis Suppurativa.

Jørgensen AR, Yao Y, Thomsen SF.

Case Rep Dermatol Med. 2018 Apr 16;2018:8685136. doi: 10.1155/2018/8685136. eCollection 2018.

20.

Comorbidities in vitiligo: comprehensive review.

Dahir AM, Thomsen SF.

Int J Dermatol. 2018 Oct;57(10):1157-1164. doi: 10.1111/ijd.14055. Epub 2018 May 28. Review.

PMID:
29808541

Supplemental Content

Loading ...
Support Center